SARS & MERS

Bojkova D, McGreig JE, McLaughlin K-M, Masterson SG, Widera M, Krähling V, et al. (Apr 5, 2020). SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles. bioRxiv [PREPRINT]. https://doi.org/10.1101/2020.04.03.024257

Taiaroa G, Rawlinson D, Featherstone L, Pitt M, Caly L, Druce J, et al. (Apr 3, 2020). Direct RNA sequencing and early evolution of SARS-CoV-2. bioRxiv [PREPRINT]. https://doi.org/10.1101/2020.03.05.976167

Wan WY, Lim SH, Seng EH (Mar 23, 2020). Cross-reaction of sera from COVID-19 patients with SARS-CoV assays. medRxiv [PREPRINT]. https://doi.org/10.1101/2020.03.17.20034454

Doremalen Nv, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, et al. (Mar 17, 2020). Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med 2020 [ONLINE]. https://doi.org/10.1056/NEJMc2004973

Lv H, Wu N, Tsang OTY, Yuan M, Perera RAPM, Leung WS, et al. (Mar 17, 2020). Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. bioRxiv [PREPRINT]. https://doi.org/10.1101/2020.03.15.993097

Rockx B, Kuiken T, Herfst S, Bestebroer T, Lamers MM, Meulder Dd, et al. (Mar 17, 2020). Comparative Pathogenesis Of COVID-19, MERS And SARS In A Non-Human Primate Model. bioRxiv [PREPRINT]. https://doi.org/10.1101/2020.03.17.995639

Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY (Mar 16, 2020). SARS-CoV-2 and COVID-19: The most important research questions. Cell & Bioscience 10, 40. https://doi.org/10.1186/s13578-020-00404-4

Yanga Y, Peng F, Wang R, Guan K, Jiang T, Xu G, et al. (Mar 3, 2020). The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of Autoimmunity [CORR. PROOF], 102434. https://doi.org/10.1016/j.jaut.2020.102434

Coronaviridae Study Group (CSG) of the International Committee on Taxonomy of Viruses (Mar 2, 2020). The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 [Cf. Feb 11 preprint by Gorbalenya et al.]. Nature Microbiology 5, 536–544. https://doi.org/10.1038/s41564-020-0695-z

Park M, Thwaites RS, Openshaw PJM (Feb 27, 2020). COVID-19: Lessons from SARS and MERS. European Journal of Immunology 50, 308–316. https://doi.org/10.1002/eji.202070035

Bhadelia N (Feb 11, 2020). Coronavirus: hospitals must learn from past pandemics. Nature 578, 193. https://doi.org/10.1038/d41586-020-00354-4

Chen Y, Liu Q, Guo D (Jan 22, 2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 92(4):418-423. https://doi.org/10.1002/jmv.25681

Ahmadzadeha J, Mobarakia K, Mousavi SJ, Aghazadeh-Attari J, Mirza-Aghazadeh-Attari M, Mohebbia I (Mar 2020). The risk factors associated with MERS-CoV patient fatality: A global survey. Diagnostic Microbiology and Infectious Disease 96(3), 114876. https://doi.org/10.1016/j.diagmicrobio.2019.114876

Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A (Apr 18, 2018). Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. The Lancet Infectious Diseases 18(8), e217-e227. https://doi.org/10.1016/S1473-3099(18)30127-0

Reperant LA, Osterhausab ADME (Aug 16 2017). AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next? Vaccine 35(35), Part A, 4470-4474. https://doi.org/10.1016/j.vaccine.2017.04.082

Kim CJ, Choi WS, Jung Y, Kiem S, Seol HY, Woo HJ, et al. (Oct 2016). Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity. Clinical Microbiology and Infection 22(10), 880-886. https://doi.org/10.1016/j.cmi.2016.07.017

Kim JY, Song JY, Yoon YK, Choi SH, Song YG, Kim SR, et al. (2015). Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities. Infection & Chemotherapy 47(4), 278-302. http://dx.doi.org/10.3947/ic.2015.47.4.278

O’Brien SJ, Troyer JL, Roelke M, Marker L, Pecon-Slattery J (Aug 2006). Plagues and adaptation: Lessons from the Felidae models for SARS and AIDS. Biological Conservation 131(2), 255-267. https://doi.org/10.1016/j.biocon.2006.05.001

Lai MYY, Cheng PKC, Lim WWL (Oct 1, 2005). Survival of Severe Acute Respiratory Syndrome Coronavirus. Clin Infect Dis 41(7):e67–e71. https://doi.org/10.1086/433186

Degnah AA, Al-amri SS, Hassan AM, Almasoud AS, Mousa M, Almahboub SA, et al. (Jan 28, 2020). Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016. Journal of Infection and Public Health [CORR. PROOF]. https://doi.org/10.1016/j.jiph.2020.01.001

Farooq HZ, Davies E, Ahmad S, Machin N, Hesketh L, Guiver M, Turner AJ (Jan 28, 2020). Middle East respiratory syndrome coronavirus (MERS-CoV) — Surveillance and testing in North England from 2012 to 2019. International Journal of Infectious Diseases 93, 237-244. https://doi.org/10.1016/j.ijid.2020.01.043

Alfaraj SH, Al-Tawfiq JA, Memish ZA (Mar 2019). Middle East respiratory syndrome coronavirus intermittent positive cases: Implications for infection control. American Journal of Infection Control 47(3), 290-293. https://doi.org/10.1016/j.ajic.2018.08.020

Hashem AM, Al-amri SS, Al-subhi TL, Siddiq LA, Hassan AM, Alawi MM, et al. (Mar 2019). Development and validation of different indirect ELISAs for MERS-CoV serological testing. Journal of Immunological Methods 466, 41-46. https://doi.org/10.1016/j.jim.2019.01.005

Subbaram K, Kannan H, Gatasheh MK (2017). Emerging Developments on Pathogenicity, Molecular Virulence, Epidemiology and Clinical Symptoms of Current Middle East Respiratory Syndrome Coronavirus (MERS-CoV). HAYATI Journal of Biosciences 24(2), 53-56. https://doi.org/10.1016/j.hjb.2017.08.001

Inagaki K, Song M-S, Crumpton J-C, DeBeauchamp J, Jeevan T, Tuomanen EI, et al. (Feb 1, 2016). Correlation Between the Interval of Influenza Virus Infectivity and Results of Diagnostic Assays in a Ferret Model. J Infect Dis 213(3): 407–410. https://doi.org/10.1093/infdis/jiv331

Nikiforuk AM, Leung A, Cook BWM, Court DA, Kobasa D, Theriaul SS (2016). Rapid one-step construction of a Middle East Respiratory Syndrome (MERS-CoV) infectious clone system by homologous recombination. Journal of Virological Methods 236, 178-183. https://doi.org/10.1016/j.jviromet.2016.07.022

Corman VM, Ölschläger S, Wendtner CM, Drexler JF, Hess M, Drosten C (2014). Performance and clinical validation of the RealStar® MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA. Journal of Clinical Virology 60(2), 168-171. https://doi.org/10.1016/j.jcv.2014.03.012

Cho S, Park L, Chong R, Kim YT, Lee JH (2014). Rapid and simple G-quadruplex DNA aptasensor with guanine chemiluminescence detection. Biosensors and Bioelectronics 52(15), 310-316. https://doi.org/10.1016/j.bios.2013.09.017

Keyaerts E, Vijgen L, Maes P, Duson G, Neyts J, Ranst MV (2006). Viral load quantitation of SARS-coronavirus RNA using a one-step real-time RT-PCR. International Journal of Infectious Diseases 10(1), P32-37. https://doi.org/10.1016/j.ijid.2005.02.003

Li YH, Li J, Liu XE, Wang L, Li T, Zhou YH, Zhuang H (2005). Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum: Comparison with results of other viral markers. Journal of Virological Methods 130(1–2), 45-50. https://doi.org/10.1016/j.jviromet.2005.06.001

Chu CM, Leung WS, Cheng VCC, Chan KH, Lin AWN, Chan VL, et al. (Jan 1, 2005). Duration of RT-PCR positivity in severe acute respiratory syndrome. Eur Respir J 25(1):12–14. https://doi.org/10.1183/09031936.04.00057804